Furthermore, by comparing the expression of CSRP1 in 23 normal bone marrow (NBM) and 224 newly diagnosed AML patients in the ZZU cohort, we confirmed that CSRP1 was overexpressed in AML (Fig. 1C). This evidence concerns the gene CSRP1 and acute myeloid leukemia.